Center for Contemporary Sciences launches to advance human-specific research models that will end animal testing
Posted on 2020-09-22A new organization in the biomedical field has launched with a mission to improve lives through education, funding and championing scientific innovation based on human biology.
Center for Contemporary Sciences (CCS) is an independent 501(c)3 organization that is advancing human-specific research methods and testing to improve lives. The organization will serve as a hub of the latest information, resources and innovation in the biomedical field.
The team at CCS includes researchers, doctors and experts with diverse backgrounds in biomedical sciences. “Our end goal is to help create a biomedical research paradigm that delivers safe and effective therapies faster and more efficiently. By doing so, we can deliver true hope to patients suffering from currently untreatable diseases, and to their families. We can heal ourselves without harming animals and do so more quickly,” shared Dr. Aysha Akhtar, President and CEO of CCS.
One of the ways they hope to enrich the scientific field is through collaboration. CCS partners with scientists, corporations, government agencies and academia to further scientific discovery. The organization is pioneering the transition to innovative human-specific medical research and testing methods including 3D human-tissue culture, human stem-cells, organ-and body-on-a-chip methods, human spheroids and organoids, bioprinting, and more.
They are committed to creating funding opportunities by connecting investors and biotech companies as well as increasing the pipeline of biomedical students to new testing technologies.
As one of their first initiatives, the Center for Contemporary Sciences is building several databases to become the “go-to” resource for the latest innovations within the biomedical field.
“Greater than 90% of drugs and vaccines fail in human clinical trials, despite showing signs of safety and efficacy in animal and traditional laboratory tests. Human-specific research approaches are, by their nature, more predictive of human biology and disease than nonhuman methods,” added Dr. Jarrod Bailey, Director of Science and Technology at CCS.
“We therefore need, urgently, to shift the focus of biomedical research and testing away from animals and towards hi-tech, cutting-edge human-based methods.”